cbdMD (YCBD) Common Stock: $0.01 Mil (As of Mar. 2026)


YCBD cbdMD Inc YCBD
38 GF Score
Price $0.69
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD Common Stock?

cbdMD YCBD +0.75% 38 Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus rates YCBD with a GF Score™ of 38/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review.

cbdMD's quarterly common stock increased from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.01 Mil) but then stayed the same from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.01 Mil).

cbdMD's annual common stock increased from Sep. 2023 ($0.00 Mil) to Sep. 2024 ($0.00 Mil) and increased from Sep. 2024 ($0.00 Mil) to Sep. 2025 ($0.01 Mil).

cbdMD Common Stock Historical Data

* Premium members only.

The historical data trend for cbdMD's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

cbdMD Common Stock Chart

cbdMD Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.00 0.00 0.00 0.01

cbdMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 0.01 0.01 0.01
YCBD
38GF Score
cbdMD Inc YCBD
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

cbdMD Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.01 Mil mean?
cbdMD (YCBD) has a Common Stock of $0.01 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on cbdMD and its competitors.
Is cbdMD's Common Stock too high?
cbdMD's current Common Stock is $0.01 Mil. Overall, cbdMD has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's Common Stock compare to AKAN and GELS?
cbdMD's Common Stock of $0.01 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on cbdMD and its competitors. cbdMD's current Common Stock is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.69 — trading 328.1% above its estimated fair value. The current Common Stock is $0.01 Mil. cbdMD's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For cbdMD (YCBD), the current Common Stock is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.69 is trading 328.1% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • Common Stock: $0.01 Mil
  • GF Value™: $0.16 vs. price of $0.69 (328.1% above fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score

Get the complete analysis for YCBD

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.69
Price
$0.16
GF Value